- Home
- ML vs AMLX Comparison
ML vs AMLX Comparison
Compare ML & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ML
- AMLX
- Stock Information
- Founded
- ML 2013
- AMLX 2014
- Country
- ML United States
- AMLX United States
- Employees
- ML N/A
- AMLX N/A
- Industry
- ML Retail: Computer Software & Peripheral Equipment
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- ML Technology
- AMLX Health Care
- Exchange
- ML Nasdaq
- AMLX Nasdaq
- Market Cap
- ML 482.3M
- AMLX 481.9M
- IPO Year
- ML N/A
- AMLX 2022
- Fundamental
- Price
- ML $78.89
- AMLX $4.76
- Analyst Decision
- ML Strong Buy
- AMLX Buy
- Analyst Count
- ML 7
- AMLX 7
- Target Price
- ML $96.17
- AMLX $6.00
- AVG Volume (30 Days)
- ML 249.5K
- AMLX 1.7M
- Earning Date
- ML 11-07-2024
- AMLX 11-07-2024
- Dividend Yield
- ML N/A
- AMLX N/A
- EPS Growth
- ML N/A
- AMLX N/A
- EPS
- ML 0.28
- AMLX N/A
- Revenue
- ML $500,281,000.00
- AMLX $196,485,000.00
- Revenue This Year
- ML $29.31
- AMLX N/A
- Revenue Next Year
- ML $21.37
- AMLX $149.49
- P/E Ratio
- ML $286.93
- AMLX N/A
- Revenue Growth
- ML 23.40
- AMLX N/A
- 52 Week Low
- ML $31.42
- AMLX $1.58
- 52 Week High
- ML $106.82
- AMLX $19.95
- Technical
- Relative Strength Index (RSI)
- ML 74.50
- AMLX 45.23
- Support Level
- ML $44.23
- AMLX $4.88
- Resistance Level
- ML $90.55
- AMLX $7.27
- Average True Range (ATR)
- ML 5.73
- AMLX 0.59
- MACD
- ML 3.22
- AMLX -0.18
- Stochastic Oscillator
- ML 75.93
- AMLX 7.03
About ML MoneyLion Inc.
MoneyLion Inc is a mobile banking and financial membership platform that empowers people to take control of their finances. It is a full-service digital platform to deliver mobile banking, lending, and investment solutions. The company offers a personalized, all-in-one, digital financial platform that provides convenient, low-cost access to banking, borrowing, and investing solutions tailored for its customers, rooted in data, and delivered through its proprietary technology platform.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.